HHV8 and EBV‐negative primary effusion‐based lymphoma: A case report of a new provisional entity and review of literature

Author:

Canelo‐Vilaseca Marta1ORCID,Tapia Gustavo2,Orna Elisa1,Sorigué Marc1,Granada Isabel1,Palomar‐Muñoz Azahara3,Castillo Ana2,Grau Javier1,Mesa Alba1,Ribera Josep‐Maria1ORCID,Sancho Juan‐Manuel1ORCID,Navarro José‐Tomás1ORCID

Affiliation:

1. Hematology Department ICO‐Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona Badalona Spain

2. Pathology Department Hospital Germans Trias i Pujol Badalona Spain

3. Nuclear Medicine‐PET (IDI) Department University Hospital of Bellvitge‐IDIBELL Barcelona Spain

Abstract

Key Clinical MessageHHV8‐ and EBV‐negative primary effusion lymphoma is an extremely rare neoplasm involving body cavities without detectable tumor mass. It usually presents in elderly patients without known immunodeficiency. Compared to primary effusion lymphoma, it has a better prognosis.Primary effusion lymphoma (PEL) is a rare non‐Hodgkin lymphoma confined exclusively to body cavities without detectable tumor masses. The term PEL‐like is an entity similar to PEL in clinical presentation but without relation to human herpesvirus 8 (HHV8). We report a case of HHV8‐ and EBV‐negative primary effusion‐based lymphoma.

Publisher

Wiley

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3